Pharmacokinetics of Peptide Mediated Delivery of Anticancer Drug Ellipticine

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Ma, Weina ^a   Lu, Sheng ^b   Pan, Pei ^a   Sadatmousavi, Parisa ^b   Yuan, Yongfang ^a   Chen, P ^b  

^a School of Medicine   (China)

^b UNIVERSITY OF WATERLOO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLGLUTAMINYLALANYLGLUTAMINYLLYSYLALANYLLYSYLALANYLGLUTAMINYLALANYLGLUTAMINYLALANYLLYSYLALANYLLYSINE; DEXAMETHASONE SODIUM PHOSPHATE; ELLIPTICINE; NANOMATERIAL; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; AREA UNDER THE CURVE; ARTICLE; BETA SHEET; BLOOD SAMPLING; CALIBRATION; COMPLEX FORMATION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG HALF LIFE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; DRUG CARRIERS; ELLIPTICINES; MALE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NANOSTRUCTURES; PEPTIDES; PROTEIN CONFORMATION; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 84865632786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043684     Document Type: Article

References (15)

1. Zhang S, (2003) Fabrication of novel biomaterials through molecular self-assembly. Nat Biotechnol 21: 1171-1178.
2. Fung SY, Hong Y, Dhadwar SS, Zhao X, Chen P (2005) Self-assembly of ionic complementary peptides and their application in nanobiotechonology. In: Nalwa HS, editors. Handbook of Nanostructured Biomaterials and Their Applications in Nanobiotechonology. Stevenson Ranch, CAUSA: American Scientific Publishers. pp 1-66.
3. Fung SY, Yang H, Chen P, (2008) Sequence effect of self-assembling peptides on the complexation and in vitro delicery of the hydrophobic anticancer drug ellipticine. PLoS One 3: e1956.
4. Bawa R, Fung SY, Shiozaki A, Yang H, Zheng G, et al. (2011) Self-assembling peptide-based nanoparticles enhance cellular delivery of the hydrophobic anticancer drug ellipticine through caveolae-dependent endocytosis. Nanomedicine In press.
5. Fung SY, Oyaizu T, Yang H, Yuan Y, Han B, et al. (2011) The potential of nanoscale combinations of self-assembling peptides and amino acids of the Src tyrosine kinase inhibitor in acute lung injury therapy. Biomaterials 32: 4000-4008.
6. Fang K, Chen SP, Lin CW, Cheng WC, Huang HT, (2009) Ellipticine-induced apoptosis depends on Akt translocation and signaling in lung epithelial cancer cells. Lung Cancer 63: 227-234.
7. Peng Y, Li C, Chen L, Sebti S, Chen J, (2003) Rescue of mutant p53 transcription function by ellipticine. Oncogene 22: 4478-4487.
8. Kuo YC, Kuo PL, Hsu YL, Cho CY, Lin CC, (2006) Ellipticine induces apoptosis through p53-dependent pathway in human hepatocellular carcinoma HepG2 cells. Life Sci 78: 2550-2557.
9. Kuo PL, Hsu YL, Chang CH, Lin CC, (2005) The mechanism of ellipticine-induced apoptosis and cell cycle arrest in human breast MCF-7 cancer cells. Cancer Lett 223: 293-301.
10. Garbett NC, Graves DE, (2004) Extending nature's leads: the anticancer agent ellipticine. Curr Med Chem Anticancer Agents 4: 149-172.
11. Sureau F, Moreau F, Millot JM, Manfait M, Allard B, et al. (1993) Microspectrofluorometry of the protonation state of ellipticine, an antitumor alkaloid, in single cells. Biophys J 65: 1767-1774.
12. Fung SY, Duhamel J, Chen P, (2006) Solvent effect on the photophysical properties of the anticancer agent ellipticine. J Phys Chem A 110: 11446-11454.
13. Bykadi G, Flora KP, Cradock JC, Poochikian GK, (1982) Determination of ellipticine in biological samples by high-performance liquid chromatography. J Chromatogr 232: 137-144.
14. Stiborova M, Rupertova M, Schmeiser HH, Frei E, (2006) Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150: 13-23.
15. Stiborová M, Borek-Dohalská L, Aimová D, Kotrbová V, Kukacková K, et al. (2006) Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes- similarity between human and rat systems. Gen Physiol Biophys 25: 245-261.